Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
13 Oct 2020	Submitted	Original manuscript
20 Oct 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
22 Oct 2020	Editorially accepted
2 Nov 2020	Article published	10.1186/s13063-020-04839-5

Back to article page